Printer Friendly
The Free Library
14,581,301 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Ovarian cancer prevention: the trial that almost didn't happen.


Women concerned about ovarian cancer ovarian cancer

Malignant tumour of the ovaries. Risk factors include early age of first menstruation (before age 12), late onset of menopause (after age 52), absence of pregnancy, presence of specific genetic mutations, use of fertility drugs, and personal history of breast
 have some good news--there s a new prevention option, one that is safe, inexpensive, and can be used by women for whom other techniques aren't an option. Recent research from the National Institutes of Health (NIH "Not invented here." See digispeak.

NIH - The United States National Institutes of Health.
) has shown that reducing dietary fat and maintaining a low-fat diet low-fat diet A diet low in fats, especially saturated fats, which has a positive effect on arthritis, CA, ASHD, DM, HTN, obesity, and strokes. See Diet, Low-fat snack; Cf Animal fat, High-fat diet.  for at least four years reduces a woman's chance of developing ovarian cancer by almost 20 percent. The only thing that's upsetting about this good news is how close we came to never learning that dietary fat is linked to the development of ovarian cancer.

The good news about ovarian cancer came from results of the Women's Health Women's Health Definition

Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues.
 Initiative's (WHI WHI Women's Health Initiative
WHI Women's Health Issues (journal)
WHI Women's Health Institute
) Dietary Modification randomized controlled trial A randomized controlled trial (RCT) is a scientific procedure most commonly used in testing medicines or medical procedures. RCTs are considered the most reliable form of scientific evidence because it eliminates all forms of spurious causality. , which lasted from 1993 until 2005 and included 48,000 women volunteers. Two-thirds of these women were counseled about general recommendations for healthy eating; these women became the control group. The other one-third (19,000 women) were randomly chosen to receive the intervention to help women to lower their fat intake through intensive nutrition courses and regular support group meetings. Researchers hoped that the low-fat diet would lead to significantly lower rates of breast and colon cancer colon cancer, cancer of any part of the colon (often called the large intestine). Colon cancer is the second most common cancer diagnosed in the United States. , as well as possibly reduced risks of ovarian and endometrial cancers. The WHI Dietary Modification trial was, by far, the largest study of cancer prevention in women.

But, it almost didn't happen. To understand why, we have to go back almost 20 years, and look at the National Cancer Institute's (NCI See Liberate. ) record of support for prevention research like Dietary Modification trial. Preliminary research showed a promising association between lower dietary fat and reduced cancer rates, but the NCI repeatedly turned down requests to fund a dietary intervention trial. The NWHN NWHN National Women's Health Network  organized letter-writing efforts in support of this research, to no avail. It took much broader campaigns that highlighted multiple examples of badly needed women's health research before the NIH finally responded--with the Women's Health Initiative--in 1992. The Dietary Modification trial was a sister study to the WHI's better-known hormone therapy trial. It's safe to say that without the activism of NWHN members and colleagues, the WHI would never have been conducted. (See The Women's Health Activist, May/June 2006, and July/August 2006 for more on the WHI.)

Now that we've got this good news about a low-fat diet's role in reducing ovarian cancer, what does it mean for women? Ovarian cancer isn't the most common women's cancer (that distinction goes to breast cancer), but it is one of the most feared, and for good reason. There are no good screening tests for ovarian cancer, and symptoms of the disease are often vague. As result, most cases are diagnosed when the cancer has already spread, and cures are difficult to come by.

Luckily, ovarian cancer is relatively rare, and most women can go through life without worrying about it. Rare isn't the same as non-existent, however, and 22,000 women in the U.S. are diagnosed with ovarian cancer annually, and 15,000 women die of the disease every year. With no screening test, and no easily recognizable early warning symptoms, women who are concerned about the disease have little recourse but to explore prevention. Until recently, oral contraceptives provided the only well-established way for healthy women to lower their risk of ovarian cancer short of surgically removing their ovaries--something the NWHN opposes to in all but the most extreme circumstances. But birth control pills are an option only for younger women and ovarian cancer, like almost all cancers, is most common in older women--the average age at diagnosis is 65.

But now, older women have a prevention option--thanks to the activism of NWHN members and other advocates who pushed for the trial that almost didn't happen. To learn more about the low-fat eating pattern followed by women in the WHI trial, go to the WHI Participants website, and look for information under "Findings": (www.whi.org/ findings/dm/cancer.php) or "FAQ (Frequently Asked Questions) A group of commonly asked questions about a subject along with the answers. Vendors often display them on their Web sites for use as troubleshooting guidelines. ": (www.whi.org/faq/faq_ dm.php--question 9). And, to help yourself and your practitioner better recognize symptoms of ovarian cancer, we recommend the Ovarian Cancer Symptom Consensus Statement distributed by the National Ovarian Cancer Alliance (www.ovariancancer.org).

REFERENCES

(1) Prentice, RL, Thomson, CL, Caan, B, et al. "Low Fat Dietary Pattern and Cancer Incidence in the Women's Health Initiative Women's Health Initiative A 15-yr, $628 million project involving 1. An observational study of the health habits and medical Hx of ±100,000 ♀ 2.  Dietary Modification Randomized Controlled Trial," JNCI JNCI Journal of the National Cancer Institute
JNCI Juniper Networks Certified Instructor
 2007; 99: 1534-43.

(2) Pearson, C, "The Trials of the Women's Health Trial," The Network News, Jan/Feb 1991, p. 1.

(3) Pearson, C, "What Can the Women's Health Initiative Tell us About How to Age Healthfully health·ful  
adj.
1. Conducive to good health; salutary.

2. Healthy. See Usage Note at healthy.



health
: Part I," The Women's Health Activist, May/June 2006, p. 4; and "What Can the Women's Health Initiative Tell us About How to Age Healthfully: Part 2," The Women's Health Activist, July/August 2006, p. 6.

Cynthia Pearson is the NWHN's Executive Director
COPYRIGHT 2008 National Women's Health Network
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Author:Pearson, Cynthia
Publication:Women's Health Activist
Date:Jan 1, 2008
Words:804
Previous Article:NWHN's fall reception: a celebration 20 years in the making.(National Women's Health Network)
Next Article:New pregnancy exposure website.(Medical condition overview)(Website overview)
Topics:



Related Articles
New hope for ovarian cancer.(Preventing Cancer: What We Know Today)
Exercise & Ovarian cancer.(exercise reduces risk)(Brief Article)
Angstrom starts Phase II cancer trial: San Diego-based privately held biopharmaceutical firm.(Biotech)(Brief Article)
Research suggests tea may decrease ovarian cancer.(World News (Coffee and Tea Reports from the Front Line))
Chemoprevention: A 21st century shell game?
A recent study revealed that ovarian cancer, often referred to as a 'silent disease,' may not be so silent after all.(WOMEN'S HEALTH SNAPSHOTS)(Brief...
APPROVAL FOR U.K. CLINICAL TRIAL FOR REOLYSIN.
Elevated vitamin D reduces cancer risk.(IN THE NEWS)
Use of oral contraceptives linked to a lower risk of ovarian cancer.(Cancer prevention)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles